We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 527.00
Bid: 525.00
Ask: 529.00
Change: -3.00 (-0.57%)
Spread: 4.00 (0.762%)
Open: 530.00
High: 533.00
Low: 524.00
Prev. Close: 530.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim results

8 Dec 2016 07:00

RNS Number : 2563R
Polar Capital Holdings PLC
08 December 2016
 

Polar Capital Holdings plc ("Polar Capital" or "the Group")

Interim results for six months ended 30 September 2016

 

Summary of Results

Financial

· Assets under Management ("AUM") at 30 September 2016 were £7.7bn/$9.9bn (31 March 2016: £7.3bn/$10.4bn) - fund outflows of £763m offset by market and currency movements of £1.1bn

· Core operating profit, excluding performance fees, £9.2m (30 September 2015: £12.4m)

· Operating profit before share-based payments £11.2m (30 September 2015: £13.3m)

· Pre-tax profit £9.1m (30 September 2015: £11.7m)

· Basic earnings per share 7.40p (30 September 2015: 10.44p) and adjusted* diluted earnings per share 9.33p (30 September 2015: 11.46p)

· Interim dividend per ordinary share of 5.5p declared (2015: 5.5p) to be paid in January 2017

· Shareholders' funds £65.4m (30 September 2015: £69.7m) including cash and investments of £71.8m (30 September 2015: £75.1m)

* Adjusted to exclude cost of share-based payments

 

Corporate

· Our UK Value long-only UCITS fund will be launched at the end of January

 

Current Trading

AUM at 30 November 2016 were £8.1bn/$10.2bn

 

Tim Woolley, Chief Executive Officer, commented:

"This was certainly a challenging period to navigate with considerable uncertainty leading up to the EU referendum and considerable volatility in markets after the result. Long-only equity funds in general experienced large net redemptions over the period and we were not immune from such industry conditions. Despite the overall challenging market conditions, a number of our funds including Biotechnology, Insurance, Global Alpha, European Income ex UK, Global Convertible Bond and UK Absolute did see net inflows over the period.

 

Our fund inflows have picked up markedly since the US election but it remains too early to suggest this is a reversal of the difficult industry conditions that we experienced through the first seven months of our financial year.

 

Overall we have become somewhat more positive on the outlook for our business over the second half of the financial year. We also expect to maintain the dividend for the current financial year."

 

 

 

For further information please contact:

Polar Capital

Tim Woolley (CEO)

John Mansell (COO)

 

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

Kit Stephenson

 

+44 (0)20 7523 8000

Peel Hunt - Joint Broker

Guy Wiehahn

 

+44 (0) 20 7418 8893

Camarco

Ed Gascoigne-Pees

Georgia Edmonds

+44 (0)20 3757 4984

 

 

Assets Under Management (AUM)

 

 

AUM split by strategy

30 September 2016

 

31 March 2016

$bn

£bn

%

$bn

£bn

%

Long only

8.84

6.81

88.9%

Long only

9.38

6.53

89.9%

Alternative

1.10

0.85

11.1%

Alternative

1.05

0.73

10.1%

$9.94bn

£7.66bn

$10.43bn

£7.26bn

 

 

 

 

AUM split by Business Unit

(in chronological order)

 

30 September 2016

 

31 March 2016

$bn

£bn

%

$bn

£bn

%

Technology

2.31

1.78

23.2%

Technology

1.98

1.38

19.0%

Japan

1.40

1.09

14.2%

Japan

2.18

1.51

20.9%

European

0.44

0.34

4.4%

European

0.55

0.38

5.3%

Healthcare

1.34

1.03

13.5%

Healthcare

1.32

0.92

12.6%

Financials

1.12

0.86

11.3%

Financials

1.05

0.73

10.1%

Emerging Markets

0.54

0.41

5.4%

Emerging Markets

0.51

0.36

4.9%

Convertibles

0.57

0.44

5.7%

Convertibles

0.45

0.31

4.3%

North America

1.95

1.50

19.6%

North America

2.20

1.53

21.0%

Global Alpha

0.11

0.09

1.1%

Global Alpha

0.10

0.07

1.0%

UK Absolute Equity

0.09

0.07

0.9%

UK Absolute Equity

0.05

0.04

0.5%

European Income

0.07

0.05

0.7%

European Income

0.04

0.03

0.4%

$9.94bn

£7.66bn

$10.43bn

£7.26bn

 

 

 

 

Chief Executive's Statement

Profit before tax fell 22% to £9.1m for the first six months of this financial year compared to the same period last year whilst adjusted diluted earnings per share fell 19% to 9.33p. The fall in profits reflects the fall in the average AUM over the period. The breakdown of the profit before tax figure is set out below.

 

Six months to

30 September 2016

Six months to

30 September 2015

Net core operating profit

£9.2m

£12.4m

Finance income

£2.0m

£0.9m

Operating profit before share-based payments and tax

£11.2m

£13.3m

Share-based payments

£(2.1)m

£(1.6)m

Profit before tax

£9.1m

£11.7m

Adjusted diluted earnings per share (non-GAAP measure)

9.33p

11.46p

 

This was certainly a challenging period to navigate with considerable uncertainty leading up to the EU referendum and considerable volatility in markets after the result. Long-only equity funds in general experienced large net redemptions over the period and we were not immune from such industry conditions. We had significant redemptions from our Japan and North America UCITS funds and from our Forager hedge fund. Net outflows across all our funds for the six months totalled £763m. Although our AUM increased over the period in sterling terms from £7.26bn to £7.66bn, this was due to market and currency movements of £1.1bn more than offsetting the aforementioned outflows. In dollar terms our AUM fell over the period from $10.43bn to $9.94bn.

 

Despite the overall challenging market conditions, a number of our funds did see inflows over the period. On the UCITS long only funds side we had net inflows into Biotechnology, Insurance, Global Alpha and European Income ex UK. On the Alternative side we actually experienced overall net inflows, with flows into our two absolute UCITS funds, Global Convertible Bond and UK Absolute, more than offsetting outflows on the Cayman hedge funds.

 

Since the end of our financial half-year the US presidential election has been decided and, as with Brexit, the pollsters were surprised and the intelligentsia were shocked at the outcome. It is too early to understand fully the implications of a Trump presidency but it would appear to be more positive for equities than bonds, with lower taxes and less regulation benefitting business. The bond market though will have to accommodate a potentially large increase in US government borrowing which will be required to fund the substantial increase in infrastructure spending Trump seems genuinely committed to delivering. The main concern now though is whether Trump's pre-election rhetoric on trade and protectionism will be enacted or, as seems more likely, will prove to have been 'election rhetoric' and his administration will in reality take a more pragmatic approach.

 

Our fund inflows have picked up markedly since the US election with inflows into a wide range of funds but notably Healthcare Opportunities, Biotechnology, Healthcare Blue Chip, North America, Insurance and Income Opportunities. It is though too early to suggest this is a reversal of the difficult industry conditions that we experienced through the first seven months of our financial year.

 

There remains the possibility of further redemptions on our Japan fund although performance has picked up markedly over the last three months and market conditions are turning decidedly more favourable to the team's style.

We will have further redemptions of around $62m on the hedge fund side this quarter as we have decided to close our ALVA hedge fund strategy at the end of December. The Global Convertible team wishes to focus on its successful UCITS product, the Global Convertible Bond fund, which has grown rapidly over the last eighteen months.

 

Our UK Value long only UCITS fund will be launched at the end of January. The fund will be managed by Georgina Hamilton and she will be joined by George Godber in April. Whilst the fund will not materially impact results for the current financial year, we believe the team has the potential to make a significant contribution in fiscal 2018 and beyond.

 

Overall we have become somewhat more positive on the outlook for our business over the second half of the financial year. We also expect to maintain the dividend for the current financial year.

 

Tim Woolley

Chief Executive 7 December 2016

 

Interim Consolidated Statement of Profit or Loss

For the six months to 30 September 2016

 

(Unaudited)

Six months to 30 September 2016

£'000

(Unaudited)

Six months to 30 September 2015

£'000

Revenue

33,637

39,862

Finance income/ (expense)

2,068

879

Gross income

35,705

40,741

Commissions and fees payable

(2,999)

(3,971)

Net income

32,706

36,770

Operating costs before share-based payments

(21,462)

(23,481)

Operating profit before share-based payments and tax

11,244

13,289

Share-based payments

(2,107)

(1,597)

Profit for the period before tax

9,137

11,692

Taxation

(2,460)

(2,474)

Profit for the period attributable to ordinary shareholders

6,677

9,218

Basic earnings per ordinary share

7.40p

10.44p

Diluted basic earnings per ordinary share

7.09p

9.77p

Adjusted basic earnings per ordinary share (Non GAAP measure)

9.74p

12.25p

Adjusted diluted earnings per ordinary share (Non GAAP measure)

9.33p

11.46p

 

All of the items in the above statements are derived from continuing operations.

 

 

Interim Consolidated Statement of Other Comprehensive Income

For the six months to 30 September 2016

 

(Unaudited)

Six months to 30 September 2016

£'000

(Unaudited)

Six months to 30 September 2015

£'000

Profit for the period attributable to ordinary shareholders

6,677

9,218

Other comprehensive income - items that may be reclassified to income statement in subsequent periods (net of tax):

Net movement on the fair valuation of cash flow hedges

(582)

650

Exchange differences on translation of foreign operations

30

(3)

Other comprehensive income for the period, net of tax

(552)

647

Total comprehensive income for the period, net of tax, attributable to ordinary shareholders

6,125

9,865

 

Interim Consolidated Balance Sheet

As at 30 September 2016

(Unaudited)

30 September 2016

£'000

(Audited)

31 March

2016

£'000

Non-current assets

Property, plant and equipment

2,637

2,862

Deferred tax assets

2,700

3,654

Total non-current assets

5,337

6,516

Current assets

Assets at fair value through profit or loss

27,943

33,293

Assets held for sale

11,626

6,835

Trade and other receivables

9,338

7,984

Cash and cash equivalents

32,181

48,762

Total current assets

81,088

96,874

Total assets

86,425

103,390

Non-current liabilities

Provisions and other liabilities

2,248

2,132

Deferred tax liabilities

112

124

Total non-current liabilities

2,360

2,256

Current liabilities

Trade and other payables

12,761

21,235

Other financial liabilities

3,782

2,966

Current tax liabilities

2,136

1,332

Total current liabilities

18,679

25,533

Total liabilities

21,039

27,789

Net assets

65,386

75,601

Capital and reserves

Issued share capital

2,283

2,280

Share premium

18,657

18,509

Investment in own shares

(878)

(878)

Capital and other reserves

5,434

6,897

Retained earnings

39,890

48,793

Total equity - attributable to ordinary shareholders

65,386

75,601

 

Interim Consolidated Statement of Changes in Equity

For the six months to 30 September 2016

 

Issued

share capital £'000

Share premium £'000

Investment

in own shares

£'000

Capital reserves £'000

Other reserves £'000

Retained earnings £'000

Total equity £'000

As at 31 March 2016 (audited)

2,280

18,509

(878)

123

6,774

48,793

75,601

Profit for the period

-

-

-

-

-

6,677

6,677

Other comprehensive income

-

-

-

-

(552)

-

(552)

Total comprehensive income

-

-

-

-

(552)

6,677

6,125

Issue of shares against options

3

148

-

-

-

(104)

47

Dividends paid

-

-

-

-

-

(17,583)

(17,583)

Share-based payment

-

-

-

-

-

2,107

2,107

Current tax in respect of employee share options

-

-

-

-

45

-

45

Deferred tax in respect of employee share options

-

-

-

-

(956)

-

(956)

As at 30 September 2016 (unaudited)

2,283

18,657

(878)

123

5,311

39,890

65,386

 

As at 31 March 2015 (audited)

2,232

16,715

(962)

133

6,532

50,581

75,231

Profit for the period

-

-

-

-

-

9,218

9,218

Other comprehensive income

-

-

-

-

647

-

647

Total comprehensive income

-

-

-

-

647

9,218

9,865

Issue of shares against options

15

-

72

-

-

(15)

72

Dividends paid

-

-

-

-

-

(17,188)

(17,188)

Share-based payment

-

-

-

-

-

1,597

1,597

Current tax in respect of employee share options

-

-

-

-

-

-

-

Deferred tax in respect of employee share options

-

-

-

-

95

-

95

As at 30 September 2015 (unaudited)

2,247

16,715

(890)

133

7,274

44,193

69,672

 

Interim Consolidated Cash Flow Statement

For the six months to 30 September 2016

(Unaudited)

Six months to 30 September

2016

£'000

(Unaudited)

Six months to 30 September

2015

£'000

Operating activities

Cash (used) /generated from operations

(449)

2,282

Tax paid

(1,447)

(2,576)

Net cash flow from operating activities

(1,896)

(294)

Investing activities

Interest received and similar income

19

9

Purchase of property, plant and equipment

(28)

(322)

Purchase of assets at fair value through profit or loss

-

(9)

Disposal of assets at fair value through profit or loss

9,975

-

Purchase of assets held for sale

(3,836)

(6)

Cash flows related to derivatives

(3,277)

1,483

Net cash flow from investing activities

2,853

1,155

Financing activities

Dividends paid

(17,583)

(17,188)

Issue of ordinary shares

45

-

Receipts in relation to investments in own shares

-

72

Net cash flow from financing activities

(17,538)

(17,116)

Net decrease in cash and cash equivalents

(16,581)

(16,255)

Cash and cash equivalents at start of period

48,762

41,385

Cash and cash equivalents at end of period

32,181

25,130

 

 

Notes to the Unaudited Interim Consolidated Financial Statements

For the six months to 30 September 2016

 

1. General Information, Basis of Preparation and Accounting Policies

Polar Capital Holdings plc ("the Company") is a public limited Company registered in England and Wales.

The unaudited interim condensed consolidated financial statements to 30 September 2016 have been prepared in accordance with IAS 34: Interim Financial Reporting.

The unaudited interim condensed consolidated financial statements do not include all the information and disclosures required in annual financial statements, and should be read in conjunction with the Group's annual financial statements as at 31 March 2016 which have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union and the Companies Act 2006 applicable to companies reporting under IFRS.

The accounting policies adopted in the preparation of the unaudited interim condensed consolidated financial statements are consistent with those used in the preparation of the Group's annual financial statements for the year ended 31 March 2016.

2. Revenue

(Unaudited)

Six months to 30 September 2016

£'000

(Unaudited)

Six months to 30 September 2015

£'000

Investment management fees

34,609

40,374

Investment advisory fees

42

-

Investment performance fees

-

42

Loss on hedging

(1,014)

(554)

33,637

39,862

 

3 Profit on Ordinary Activities Before Taxation

3.1) This is stated after charging:

(Unaudited)

Six months to 30 September 2016

£'000

(Unaudited)

Six months to 30 September 2015

£'000

Staff costs

15,075

17,405

Depreciation

253

197

Operating lease rentals - land & buildings

654

637

Operating lease rentals - other

860

642

 

3.2) Auditors' remuneration:

Audit of group financial statements

27

24

Other fees

- local statutory audits of subsidiaries

20

18

- GIPS Review

11

11

- internal controls review

25

24

- tax advisory services

17

2

 

4. Taxation

The tax charge for the six months ended 30 September 2016 includes a charge for share-based payment costs of £440,000 (September 2015: £160,000) that were not deductible for tax purposes. Under UK tax legislation the Group is only allowed a deduction for share-based payment costs when options are exercised by employees. When compared to the comparative period, the smaller number of option exercises in 2016 and the lower Group share price has resulted in a higher proportion of the accounting share-based payment cost being disallowed for tax purposes during the current period.

 

5. Dividends

(Unaudited)

Six months to 30 September 2016

£'000

(Unaudited)

Six months to 30 September 2015

£'000

Dividend paid

17,583

17,188

 

6. Earnings Per Ordinary Share

The calculation of basic earnings per ordinary share is based on the profit for the period of £6,676,500 (September 2015: profit £9,217,800) and on 90,177,700 (September 2015: 88,255,362) ordinary shares, being the weighted number of ordinary shares.

The calculation of diluted basic earnings per ordinary share is based on the profit for the period of £6,676,500 (September 2015: profit £9,217,800) and 94,180,600 (September 2015: 94,356,332) ordinary shares, being the weighted average number of ordinary shares allowing for all options of 4,002,900 (September 2015: 5,683,882) which are dilutive as well as shares granted under a crystallisation event but not yet issued of nil (September 2015: 417,088).

The calculation of adjusted basic earnings per ordinary share is based on a profit for the period of £6,676,500 (September 2015: profit of £9,217,800) but adjusted for the share-based payments charge of £2,107,700, (September 2015: share base payments charge of £1,597,500) and on 90,177,700 (September 2015: 88,255,362) ordinary shares, being the weighted number of ordinary shares.

The calculation of adjusted diluted earnings per ordinary share is based on a profit for the period of £6,676,500 (September 2015: £9,217,800) but adjusted for the share-based payments charge of £2,107,700, (September 2015: share base payments charge of: £1,597,500) and 94,180,600 (September 2015: 94,356,332) ordinary shares being the weighted average number of ordinary shares allowing for all options of 4,002,900 (September 2015: 5,683,882 ) which are dilutive as well as shares granted under a crystallisation event but not yet issued of nil (September 2015: 417,088).

 

7. Notes to the Cash Flow Statement

Reconciliation of profit before taxation to cash generated from operations

(Unaudited)

Six months to 30 September 2016

£'000

(Unaudited)

Six months to 30 September 2015

£'000

Cash flows from operating activities

Profit on ordinary activities before tax

9,137

11,692

Adjustments for:

Interest received

(19)

(9)

Depreciation of property, plant and equipment

253

197

Increase in trade and other receivables

(1,354)

(297)

Decrease in trade and other payables

(8,474)

(9,645)

(Gain)/ loss on financial assets at fair value through profit or loss

(4,624)

2,480

Increase in non-current provisions and other liabilities

116

-

Loss/ (gain) on financial instruments at fair value through profit or loss

 

3,364

 

(2,954)

Gain on assets held for sale

(955)

(779)

Share-based payment

2,107

1,597

Cash (used)/ generated from operations

(449)

2,282

 

 

8. Related Party Transactions

Transactions between the Company and its subsidiaries, which are related parties of the Company, have been eliminated on consolidation and are not included in this note.

B J D Ashford-Russell is a member of Polar Capital LLP and a director of the Polar Capital Technology Trust plc (the Trust). Polar Capital LLP is the appointed investment manager of the Trust. The total fees received by the Group as investment manager of the Trust were £4,290,300 (September 2015: £3,912,500). The amounts receivable at period end in this respect were £1,628,000 (March 2016: £1,319,000).

At the end of the period, the Group had an outstanding loan due of £877,700 (March 2016: £877,700) from the Polar Capital Employee Benefit Trust, which was set up in 2002 to hold ordinary shares in Polar Capital Holdings plc for the benefit of employees.

9. The Publication of Non-Statutory Accounts

The financial information contained in this unaudited half year report does not constitute statutory accounts as defined in S434 of the Companies Act 2006. The financial information for the six months ended 30 September 2016 and 2015 has not been audited. The information for the year ended 31 March 2016 has been extracted from the latest published audited accounts, which have been filed with the Registrar of Companies. The audited accounts filed with the Registrar of Companies contain a report of the independent auditor dated 23 June 2016. The report of the independent auditor on those financial statements contained no qualification or statement under S498 of the Companies Act 2006.

Directors

T H Bartlam

Non-executive Chairman

T J Woolley

Chief Executive Officer

J B Mansell

Chief Operating Officer, Finance Director

H G C Aldous

Non-executive Director, Chairman of Audit Committee

B J D Ashford-Russell

Non-executive Director

G V Bumeder

Non-executive Director

J M B Cayzer-Colvin

Non-executive Director

M W Thomas

Non-executive Director, Chairman of Remuneration Committee

 

Company No.

4235369

Registered Office

16 Palace Street

London, SW1E 5JD

Tel: 020 7227 2700

Company Secretary

Neil Taylor

 

Dividend

A first interim dividend of 5.5p per share has been declared for the year to 31 March 2017. This will be paid on 13 January 2017 to shareholders on the register on 30 December 2016. The shares will trade ex-dividend from 29 December 2016.

Remuneration Code

Disclosure of the group's Remuneration Code will be made alongside its Pillar 3 disclosure which is available on the Company's website.

Half Year Report 

The Half Year report will be posted to shareholders in late December 2016. Copies of this announcement and of the Half Year report will be available from the Secretary at the Registered Office, 16 Palace Street, London SW1E 5JD and from the Company's website at www.polarcapital.co.uk 

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFITFTLDIIR
Date   Source Headline
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.